This inventor holds 1 USPTO granted patent. Top assignee: Neuren Pharmaceuticals Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Thorsten Gorba: Innovator in Neural Regeneration
Introduction
Thorsten Gorba is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of neuroscience, particularly in the area of neural regeneration. His innovative work focuses on developing therapeutic methods for treating brain damage and neurodegenerative diseases.
Latest Patents
Thorsten Gorba holds a patent for "Neural regeneration peptides and methods for their use in treatment of brain damage." This invention discloses a family of peptides known as NRP compounds or NRPs. These compounds promote neuronal migration, neurite outgrowth, neuronal proliferation, neural differentiation, and neuronal survival. The patent provides compositions and methods for using NRPs in treating brain injuries and neurodegenerative diseases. NRP compounds can induce neurons and neuroblasts to proliferate and migrate into areas of damage caused by various conditions, including toxins, stroke, trauma, and metabolic disorders. They can be administered through multiple routes, including orally and directly into the nervous system, and can be formulated into pharmaceutically acceptable dose forms for therapeutic use.
Career Highlights
Thorsten Gorba is associated with Neuren Pharmaceuticals Limited, where he continues to advance his research and development efforts. His work has the potential to significantly impact the treatment of brain injuries and neurodegenerative conditions.
Collaborations
Thorsten collaborates with esteemed colleagues, including Paul Hughes and Frank Sieg, to further enhance the research and application of his inventions.
Conclusion
Thorsten Gorba's innovative contributions to neural regeneration highlight the importance of research in developing effective treatments for brain damage and neurodegenerative diseases. His work exemplifies the potential of peptide-based therapies in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
